However, SHIP2 levels are increased in ER-negative primary breast tumours compared to normal tissues, and SHIP2 expression positively correlates with invasive disease and reduced survival, supporting a pro-tumourigenic role for SHIP2 in breast cancer [82,119,120,121,122]. This evidence concerns the gene INPPL1 and breast neoplasm.